Acromegaly Treatment Market Size, Share & Trends Analysis Report By Product (Somatostatin analogs, GHRA), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2019 - 2025

Published: Feb, 2019 | Pages: 100 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global acromegaly treatment market size is expected to reach USD 2.10 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.5% over the forecast period. Increasing incidence of the acromegaly disease is expected to drive the growth. For instance, the disease prevalence increased fourfold in 2015 from its previous year 2014, according to a report by the Endocrine Society. Moreover, growing investment in clinical trials by various pharmaceutical companies to develop new molecules is another factor propelling the market growth.

Furthermore, strong pipeline of drugs is anticipated to create growth opportunities in the forthcoming years. For instance, Mycapssa by Chiasma Inc. received approval in Europe in 2016. In 2018, Antisense Therapeutics launched their new formulation ALT1103 in U.S. ISIS 766720 by Ionis Pharmaceuticals Inc., a growth hormone receptor antagonist is currently under phase II clinical trial and is expected to be finished by December 2019.

The strong pipeline of drugs for somatostatin analogs is expected to propel growth of the acromegaly treatment market in near future. For instance, in 2018 around 30 clinical trials were being conducted in North America and many are waiting for the U.S. Food and Drug Administration (FDA) approval.

Further key findings from the report suggest:

• Somatostatin analogs segment is expected to emerge as the largest product segment in terms of revenue share in the forthcoming years, owing to easy availability and cost-effective treatment procedure of the product

• Hospital and clinics end use segment accounted for the largest market share as all the surgical procedures are performed in these facilities. Easy availability of surgeons Is anticipated to further drive the segment

• North America held the dominant market share in 2018, due to favorable government insurance policies and increased investment in R&D by the pharmaceutical companies. For instance, In May 2018, U.S. Congress approved the Right to Try bill, wherein patients can try unproven medical therapeutics in case of serious illness including orphan diseases like acromegaly

• Asia Pacific acromegaly treatment market is anticipated to witness lucrative growth in near future due to rising healthcare expenditure and R&D initiatives by pharmaceutical companies

• Some of the key players are Novartis AG; Ipsen Pharma; Pfizer Inc.; and Chiasma Inc.

 Table of Contents

Chapter 1 Report Scope
                  1.1 Segment Market Scope
                  1.2 Regional Scope
                  1.3 Estimates & Forecast Timeline

Chapter 2 Research Methodology
                  2.1 Model Details
                      2.1.1 Regression and variable analysis
                  2.2 Information Procurement
                  2.3 List Of Primary Sources
                      2.3.1 Purchased database:
                      2.3.2 GVR's internal database
                  2.4 Primary Interview Breakup
                      2.4.1 Data for primary interviews, by sources
                      2.4.2 Data for primary interviews, by region
                  2.5 List Of Secondary Sources

Chapter 3 Report Objectives
                  3.1 Objectives

Chapter 4 Executive Summary
                  4.1 Market Summary

Chapter 5 Market Definitions
                  5.1 Definitions

Chapter 6 Acromegaly Treatment market: Industry Outlook
                  6.1 Market Variable Analysis
                  6.2 Market Driver Analysis
                      6.2.1 Increasing prevalence of acromegaly
                      6.2.3 Ongoing clinical trials
                  6.3 Market Restraints Analysis
                      6.3.1 High treatment cost
                      6.3.2 Lack of awareness among people
                  6.4 Business Environment Analysis Tools
                      6.4.1 Acromegaly Treatment market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                      6.4.2 Porter's Five Forces Analysis

Chapter 7 Regulatory & Political Forces
                  7.1 Regulatory Landscape
                      7.1.1 List of regulations, by country
                      7.1.2 North America
                      7.1.4 Europe
                      7.1.5 Asia Pacific
                      7.1.7 Latin America
                      7.1.9 MEA
                  7.2 Political Landscape, Current & Future Scenario

Chapter 8 Competitive & Vendor Landscape
                  8.1 Market Participation Categorization
                      8.1.1 Market leader
                      8.1.2 Innovators
                  8.2 Strategic Initiatives & Outcome Analysis
                  8.3 List of Key Companies, By Product
                  8.4 Company Market Share Analysis
                      8.4.1 Acromegaly treatment market company market share analysis, 2017

Chapter 9 Acromegaly Treatment Market: Product Analysis
                  9.1 Product Business Analysis
                  9.2 Somatostatin analogs (SSA)
                      9.2.1 Somatostatin analogs (SSA) estimates and forecasts, 2014 - 2025 (USD Million)
                  9.3 GHRA
                      9.3.1 GHRA market estimates and forecasts, 2014 - 2025 (USD Million)
                  9.4 Others
                      9.4.1 others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 10 Acromegaly Treatment market: End Use Analysis
                  10.1 End Use Business Analysis
                  10.2 Hospitals
                      10.2.1 hospitals estimates and forecasts, 2014 - 2025 (USD Million)
                  10.3 Clinics
                      10.3.1 clinics market estimates and forecasts, 2014 - 2025 (USD Million)
                  10.4 Others
                      10.4.1 others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 11 Acromegaly Treatment Market: Regional Analysis
                  11.1 North America
                      11.1.1 North America Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.1.2 U.S.
                          11.1.2.1 U.S. Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.1.3 Canada
                          11.1.3.1 Canada Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.2 Europe
                      11.2.1 Europe Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.2 Germany
                          11.2.2.1 Germany Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.3 U.K.
                          11.2.3.1 U.K. Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.4 France
                          11.2.4.1 France Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.5 Italy
                          11.2.5.1 Italy Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.6 Spain
                          11.2.6.1 Spain Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.3 Asia Pacific
                      11.3.1 Asia Pacific Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.2 China
                          11.3.2.1 China Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.3 India
                          11.3.3.1 India Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.4 Japan
                          11.3.4.1 Japan Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.4 Latin America
                      11.4.1 LATIN America Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.4.2 Mexico
                          11.4.2.1 Mexico Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.4.3 Brazil
                          11.4.3.1 Brazil Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.5 MEA
                      11.5.1 MEA Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.5.2 South Africa
                          11.5.2.1 South Africa acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 12 Company Profiles
                  12.1 Key Company Profiles
                      12.1.1 Novartis AG
                          12.1.1.1 Company overview
                          12.1.1.2 Financial performance
                          12.1.1.3 Product benchmarking
                          12.1.1.4 Strategic initiatives
                      12.1.2 Ipsen Pharma
                          12.1.2.1 Company overview
                          12.1.2.2 Financial performance
                          12.1.2.3 Product benchmarking
                          12.1.2.4 Strategic initiatives
                      12.1.3 SUN PHARMACEUTICAL INDUSTRIES LTD.
                          12.1.3.1 Company overview
                          12.1.3.2 Product benchmarking
                          12.1.3.3 Strategic initiatives
                      12.1.4 Chiasma, Inc.
                          12.1.4.1 Company overview
                          12.1.4.2 Product benchmarking
                          12.1.4.3 Strategic initiatives
                      12.1.5 Peptron, Inc
                          12.1.5.1 Company overview
                          12.1.5.2 Financial Performance
                          12.1.5.3 Product benchmarking
                          12.1.5.4 Strategic initiatives
                      12.1.6 WOCKHARDT
                          12.1.6.1 Company overview
                          12.1.6.2 Financial performance
                          12.1.6.3 Product benchmarking
                          12.1.6.4 Strategic initiatives
                      12.1.7 Dauntless Pharmaceuticals
                          12.1.7.1 Company overview
                          12.1.7.2 Product benchmarking
                          12.1.7.3 Strategic initiatives
                      12.1.8 Pfizer Inc.
                          12.1.8.1 Company overview
                          12.1.8.2 Financial performance
                          12.1.8.3 Product benchmarking
                          12.1.8.4 Strategic initiatives
                      12.1.9 Ionis Pharmaceuticals, Inc.
                          12.1.9.1 Company overview
                          12.1.9.2 Product benchmarking
                          12.1.9.3 Strategic initiatives

Chapter 13 Recommendations/Conclusion
                  13.1 Recommendations
                  13.2 Conclusion

List of Tables

Table 1 Country share estimation
Table 2 List of regulations, by country
Table 3 List of key companies, by product
Table 4 North America acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 5 North America acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 6 U.S. acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 7 U.S. acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 8 Canada acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 9 Canada acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 10 Europe acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 11 Europe acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 12 Germany acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 13 Germany acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 14 U.K. acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 15 U.K. acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 16 Italy acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 17 Italy acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 18 France acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 19 France acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 20 Spain acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 21 Spain acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 22 Asia Pacific acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 23 Asia Pacific acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 24 Asia Pacific acromegaly treatment market, by site, 2014 - 2025 (USD Million)
Table 25 Asia Pacific acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 26 China acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 27 China acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 28 India acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 29 India acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 30 Latin America acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 31 Latin America acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 32 Mexico acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 33 Mexico acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 34 Brazil acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 35 Brazil acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 36 MEA acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 37 MEA acromegaly treatment market, by end use, 2014 - 2025 (USD Million)
Table 38 South Africa acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 39 South Africa acromegaly treatment market, by end use, 2014 - 2025 (USD Million)

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Components: TAM
Fig. 6 Information procurement
Fig. 7 Primary interviews, by sources
Fig. 8 Primary interviews, by region
Fig. 9 Acromegaly treatment market revenues, 2017, (USD Millions)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Acromegaly treatment market - SWOT analysis, by the factor (political & legal, economic and technological)
Fig. 14 Porter's five forces analysis
Fig. 15 Market participant categorization
Fig. 16 Strategy framework analysis, 2017
Fig. 17 Acromegaly treatment market share, 2017
Fig. 18 Acromegaly treatment market product outlook: Key takeaways
Fig. 19 Acromegaly treatment market: Product movement analysis
Fig. 20 Global somatostatin analog market, 2014 - 2025 (USD Million)
Fig. 21 Global GHRA market, 2014 - 2025 (USD Million)
Fig. 22 Global others market, 2014 - 2025 (USD Million)
Fig. 23 Acromegaly treatment market end use outlook: Key takeaways
Fig. 24 Acromegaly treatment market: End Use movement analysis
Fig. 25 Global hospitals & clinics market, 2014 - 2025 (USD Million)
Fig. 26 Global others market, 2014 - 2025 (USD Million)
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Regional outlook, 2014 - 2025 (USD Million)
Fig. 29 North America Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 30 U.S. Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 31 Canada Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 32 Europe Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 33 Germany Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 34 U.K. Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 35 Italy Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 36 France Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 37 Spain Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 38 Asia Pacific Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 39 China Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 40 India Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 41 Japan Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 42 Latin America Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 43 Mexico Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 44 Brazil Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 45 MEA Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 46 South Africa Acromegaly treatment market, 2014 - 2025 (USD Million)